Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Meeting lecture
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

https://precisionnanomedicine.com/feed
ISSN 2639-9431
Review
May 12, 2026 EDT

Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering

Panijapatr Wasubhadtanasaka, M.D., Ph.D.,
CisplatinCardiothoracic SurgeryCyclodextrinNephrotoxicityNanomedicineSurgical WindowStimuli-ResponsiveSurgical Reclaimability
Copyright Logoccby-nc-4.0 • https://doi.org/10.33218/001c.161262
prnano
1.
Wasubhadtanasaka P. Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering. Precis Nanomed. Published online May 12, 2026:1815-1833. doi:10.33218/001c.161262
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system